Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-06-19FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA granted supplemental approval for ADVAIR HFA (fluticasone propionate and salmeterol xinafoate) by GlaxoSmithKline LLC, updating the …
-
FDA approval · 2013-06-19FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline.
-
FDA approval · 2013-06-19FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate Diskus submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Comparison of an Electronic Version of Selected COPD PRO Instruments With the Original Versions
This clinical trial compared electronic versions of selected COPD patient-reported outcome instruments with their original versions to asses…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol [Phase 2]
This completed Phase 2 trial evaluated the efficacy and safety of AZD5423 in COPD patients who were receiving Formoterol as background thera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus [Phase 3]
Phase 3 trial comparing MF59-adjuvanted and non-adjuvanted influenza vaccines in patients with chronic pulmonary disease, chronic heart dise…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]
Phase 3 clinical trial evaluating the effect of supplemental Vitamin D on skeletal muscle function in COPD patients. The study has completed…
-
FDA approval · 2013-06-10FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
Completed the Special Drug Use Investigation for Advair Diskus (salmeterol and fluticasone) in chronic obstructive pulmonary disease. The st…
-
CLINICAL_TRIALS research · 2013-06-07Clinical Trial Update: AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients
This clinical trial update describes ambulatory oximetry monitoring as a new approach to quantify oxygen desaturation in ambulatory patients…
-
CLINICAL_TRIALS research · 2013-06-06Clinical Trial Update: Investigating the Impact of Mode of Administration on Item Response
This clinical trial update reports on an investigation into how mode of administration affects item response across conditions including chr…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Respiratory Muscle Function in COPD Exacerbations [NA]
This document provides an update on a clinical trial evaluating respiratory muscle function during COPD exacerbations.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162 [Phase 1, Phase 2]
This trial update reports safety, preliminary pharmacokinetics, and bronchodilator properties of V0162 in Phase 1/2 for chronic obstructive …
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: IVR-Enhanced Care Transition Support for Complex Patients [NA]
This clinical trial evaluated IVR-Enhanced Care Transition Support for complex patients with congestive heart failure and COPD, with results…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations [Phase 4]
A Phase 4 trial comparing two dosages of nebulized corticosteroid versus parenteral corticosteroid for management of COPD exacerbations has …
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]
A Phase 1 trial evaluating the safety and pharmacokinetics of inhaled ciprofloxacin in patients with mild to moderate chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD [Phase 4]
This Phase 4 trial update investigates how bronchodilation affects cycle versus treadmill exercise endurance time in patients with chronic o…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]
This document provides an update on a Phase 2 study characterizing pharmacodynamic profiles in subjects with Chronic Obstructive Pulmonary D…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
The update reports the completion of a Phase 2 clinical trial evaluating the pharmacodynamic response of a COPD treatment in subjects with c…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing aclidinium bromide 400 µg to placebo and to tiotropium in patients with stable moderate-to-severe chronic obstructiv…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 study evaluating systemic exposure and pharmacodynamics in patients with Chronic Obstructive Pulmonary Disease has completed.
-
CLINICAL_TRIALS research · 2013-05-16Clinical Trial Update: A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response [NA]
A completed clinical trial evaluated motivational interviewing and interactive voice response to reduce hospital readmissions in patients wi…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 trial updates the effects of tiotropium on breathing capacity and exercise limitation in early-stage chronic obstructive pulmonary d…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Urban Walking Circuits [NA]
A completed clinical trial evaluated an urban walking circuit program for individuals with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Effectiveness of Influenza Vaccine Reminder Systems [NA]
A completed clinical trial assesses the effectiveness of influenza vaccine reminder systems in improving vaccination rates among patients wi…